United States · FDA National Drug Code directory
LOMAIRA
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 17224-840_52567d07-cb5d-3c15-e063-6294a90a36ec
- Product NDC
- 17224-840
- Form
- TABLET
- Composition / generic term
- PHENTERMINE HYDROCHLORIDE
- Labeler
- Calvin Scott & Co., Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20160912
- Source listing expiry
- 20271231
Source-listed ingredients
- PHENTERMINE HYDROCHLORIDE — 8 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 21 TABLET in 1 BOTTLE (17224-840-21) · 17224-840-21
- 28 TABLET in 1 BOTTLE (17224-840-28) · 17224-840-28
- 30 TABLET in 1 BOTTLE (17224-840-30) · 17224-840-30
- 42 TABLET in 1 BOTTLE (17224-840-42) · 17224-840-42
- 60 TABLET in 1 BOTTLE (17224-840-60) · 17224-840-60
- 90 TABLET in 1 BOTTLE (17224-840-90) · 17224-840-90
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →